Up to 30% of children currently suffer from at least one allergic disease, making allergies a major burden for affected children, their families, and society. Atopic dermatitis (AD) is often the first atopic disease to develop in early childhood, and children with AD are at increased risk of subsequently developing other allergic diseases, such as asthma and food allergies.
AD is a complex inflammatory disease involving skin barrier dysfunction, immune dysregulation, and microbial dysbiosis. Environmental factors have been shown to strongly influence the risk of allergy development. For example, cesarean section and antibiotic use during pregnancy or early life have been identified as risk factors for AD. In contrast, growing up on a farm, having older siblings, or consuming a diverse diet during the first year of life have been associated with a reduced risk of allergic disease development. These factors share a common feature in that they influence the maturation of the gut and skin microbiome.
Indeed, we found that children with a highly diverse diet, including dairy products and vegetables during the first year of life, showed an increased levels of short-chain fatty acid (SCFA) and increased abundance of SCFA-producing bacteria, such as Ruminococcus bromii. SCFAs are known to promote immune tolerance toward allergens and to improve epithelial barrier integrity. Furthermore, we observed that children with high SCFA levels during the first year of life suffered significantly less frequently from allergic diseases later in life.
Children Allergy, Nutrition, and Environment (CARE) Study
The CARE study is an ongoing Swiss birth cohort study aiming to identify early-life environmental factors associated with protection against the development of AD and other allergic diseases later in life. Newborns are recruited at the University Hospital Bern and the Cantonal Hospital St. Gallen. We collect detailed longitudinal information on diet during the first year of life using questionnaires, assess the development of AD and other allergic diseases during clinical visits, and collect biological samples such as blood and feces to evaluate immune status and the gut microbiome.